Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Reports Development of Fetal Genetic Mutation Detection Method

NEW YORK, July 12 (GenomeWeb News) - Sequenom announced today that it has developed, in collaboration with an international consortium led by the Chinese University of Hong Kong and Boston University, a method of determining genetic mutations in circulating fetal nucleic acids in maternal plasma.

 

Using the company's MassArray technology, the researchers were able to detect the inheritance of the four most common Southeast Asian beta-thalassemia mutations in at-risk pregnancies between seven to 21 weeks of gestation, as well as analyze fetal haplotypes based on a genetic variation linked to the beta-globin locus HBB, Sequenom said.

 

Details of the development appear in the online early edition of the Proceedings of the National Academy of Sciences, the company noted.

 

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.